Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Acer Therapeutics Inc (NQ: ACER )

2.460 USD -0.010 (-0.40%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 17, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 49,982
Open 2.480
Bid (Size) 2.400 (5)
Ask (Size) 2.570 (1)
Prev. Close 2.470
Today's Range 2.460 - 2.560
52wk Range 2.280 - 5.390
Shares Outstanding 14,310,244
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
The Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf of Purchasers of Acer Therapeutics Inc. common stock – ACER
From GlobeNewswire News Releases
Acer Therapeutics to Participate in H.C. Wainwright 23rd Annual Global Investment Conference
From GlobeNewswire News Releases

Performance

YTD
-3.15%
-3.15%
1 Month
+2.93%
+2.93%
3 Month
-11.83%
-11.83%
6 Month
-36.92%
-36.92%
1 Year
-5.02%
-5.02%

More News

Read More
22 Million in Cash for this NASDAQ insures Operating Capital into Mid 2022; FDA Review of ACER 001 Bodes well for Acer Therapeutics Inc. (NASDAQ: ACER)
Tags Services Professional Services Hospitality
From Get News
Acer Therapeutics Reports Q2 2021 Financial Results and Provides Corporate Update
From GlobeNewswire News Releases
Acer Therapeutics and Relief Therapeutics Announce Submission of a New Drug Application to the U.S. FDA for ACER-001 for Treatment of Urea Cycle Disorders
From GlobeNewswire News Releases
RELIEF THERAPEUTICS Holdings AG: Acer Therapeutics and Relief Therapeutics Announce Submission of a New Drug Application to the U.S. FDA for ACER-001 for Treatment of Urea Cycle Disorders
From ACCESSWIRE
Advanced Pharmaceutical Therapies from this NASDAQ for Inborn Errors of Metabolism and Infectious Diseases: Acer Therapeutics Inc. (NASDAQ: ACER)
Tags Pharmaceuticals & Biotech Technology Health & Medicine
From Get News
22 Million in Cash for this NASDAQ insures Operating Capital into Mid 2022; FDA Review of ACER 001 Bodes well for Acer Therapeutics Inc. (NASDAQ: ACER)
Tags Banking, Finance & Investment Virus / Pandemic / Viral/Wire Advertising & Marketing
From Viz Release
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Tags Pre/Market Outlook SBTX MGNX
From Benzinga
Advanced Pharmaceutical Therapies from this NASDAQ for Inborn Errors of Metabolism and Infectious Diseases: Acer Therapeutics Inc. (NASDAQ: ACER)
Tags Business Consumer Products Computers & Internet
From Viz Release
12 Health Care Stocks Moving In Monday's After-Market Session
Tags SONN BTCY DFFN
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.